1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Issue 10097 (26th August 2017) Authors: Russell, Stephen; Bennett, Jean; Wellman, Jennifer A; Chung, Daniel C; Yu, Zi-Fan; Tillman, Amy; Wittes, Janet; Pappas, Julie; Elci, Okan; McCague, Sarah; Cross, Dominique; Marshall, Kathleen A; Walshire, Jean; Kehoe, Taylor L; Reichert, Hannah; Davis, Maria; Raffini, Leslie; George, Lindsey A; H... Journal: Lancet Issue: Volume 390:Issue 10097(2017) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. (31st August 2017) Authors: Chung, Daniel C; McCague, Sarah; Yu, Zi‐Fan; Thill, Satha; DiStefano‐Pappas, Julie; Bennett, Jean; Cross, Dominique; Marshall, Kathleen; Wellman, Jennifer; High, Katherine A Journal: Clinical & experimental ophthalmology Issue: Volume 46:Number 3(2018) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗